Clinical Trials Directory

Trials / Completed

CompletedNCT04085133

Prevalence and Burden of Bronchiectasis in Tuberculous Patients

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers

Summary

Bronchiectasis was described in the early 19th century by Laennec. Bronchiectasis is a chronic condition characterized by permanent and irreversible dilatation of the bronchial airways and impairment of mucociliary transport mechanism due to repeated infection and inflammation leading to colonization of organism and pooling of the mucus in the bronchial tree

Detailed description

Bronchiectasis was described in the early 19th century by Laennec. Bronchiectasis is a chronic condition characterized by permanent and irreversible dilatation of the bronchial airways and impairment of mucociliary transport mechanism due to repeated infection and inflammation leading to colonization of organism and pooling of the mucus in the bronchial tree. The prevalence of bronchiectasis is age-related and occurs in every age group and in the pre-antibiotic era . it most often began in childhood. Recent evidence shows that bronchiectasis disproportionately affects women and older individuals and will be contributing to increase in healthcare burden.\[3\] International data show an increase in the prevalence of bronchiectasis over recent years.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTGene Xpert Chest x ray and MSCT chestSputum sample for T.B will be done using gene expert device and chest xray and high resolution ct to evaluate bronchectasis

Timeline

Start date
2019-09-26
Primary completion
2020-01-01
Completion
2020-04-01
First posted
2019-09-11
Last updated
2023-02-17

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04085133. Inclusion in this directory is not an endorsement.